These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37658934)

  • 21. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
    Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment.
    Zung A; Barash G; Zadik Z; Barash J
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):155-60. PubMed ID: 16562589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.
    Atas N; Eroglu GA; Sodan HN; Ozturk BO; Babaoglu H; Satis H; Karadeniz H; Guler AA; Salman RB; Goker B; Ozturk MA; Haznedaroglu S; Tufan A
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):30-36. PubMed ID: 34251317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.
    Karabulut Y; Gezer HH; Öz N; Esen İ; Duruöz MT
    Rheumatol Int; 2022 Dec; 42(12):2211-2219. PubMed ID: 36048189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients.
    Gülez N; Makay B; Sözeri B
    Mod Rheumatol; 2020 Jan; 30(1):166-171. PubMed ID: 30556769
    [No Abstract]   [Full Text] [Related]  

  • 27. Canakinumab for the treatment of familial Mediterranean fever.
    Ozdogan H; Ugurlu S
    Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.
    Çakan M; Karadağ ŞG; Ayaz NA
    Turk J Pediatr; 2020; 62(2):167-174. PubMed ID: 32419407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gray zone in the spectrum of autoinflammatory diseases: familial Mediterranean fever accompanying periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: single-center experience.
    Konte EK; Haslak F; Yildiz M; Gucuyener N; Ulkersoy I; Gunalp A; Aslan E; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Eur J Pediatr; 2023 Dec; 182(12):5473-5482. PubMed ID: 37777601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T; Yilmaz R; Uzerk Kibar M; Erdem Y
    J Nephrol; 2018 Jun; 31(3):453-455. PubMed ID: 29446001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK; Gezgin Yildirim D; Esmeray P; Söylemezoğlu O
    Pediatr Int; 2023; 65(1):e15588. PubMed ID: 37658625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region.
    Jesenak M; Hrubiskova K; Kapustova L; Kostkova M; Banovcin P
    Bratisl Lek Listy; 2018; 119(4):198-200. PubMed ID: 29663815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.
    Druyan A; Giat E; Livneh A; Grossman C; Ben-Zvi I; Lidar M
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):75-79. PubMed ID: 34369359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V; Vinit C; Fayand A; Georgin-Lavialle S
    Front Immunol; 2020; 11():971. PubMed ID: 32670263
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial Mediterranean fever, review of the literature.
    Alghamdi M
    Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature.
    Yıldırım DG; Fidan HK; Gönen S; Söylemezoğlu O
    Turk J Pediatr; 2020; 62(2):175-181. PubMed ID: 32419408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of colchicine on physical growth in children with familial mediterranean fever.
    Ozçakar ZB; Kadioğlu G; Siklar Z; Kavaz A; Nur Aksanal F; Berberoğlu M; Ekim M; Ocal G; Yalçinkaya F
    Eur J Pediatr; 2010 Jul; 169(7):825-8. PubMed ID: 20016916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.